国内外卫生技术评估应用现状及对中医药的启示

A comparative study of domestic and international health technology assessment applications and implications for traditional Chinese medicine

关键词:  卫生技术评估  中医药特色  HTA  决策工具

Key words:  health technology assessment  traditional Chinese medicine characteristic  HTA  decision-making tool

摘要:

自1976年美国首次提出卫生技术评估概念以来，各国已不再局限于某一具体的临床治疗方式和手段的评估，转而利用卫生技术评估作为一个判断新技术准入和使用的政策工具。卫生技术评估作为提高医疗决策科学性、经济性和公平性的工具，在中医药领域的评估范畴、评估方法和评估细致程度方面应用较少，发展较慢。通过梳理欧美四国（英国、加拿大、瑞典、德国）及亚洲五国（日本、韩国、泰国、新加坡、中国）卫生技术评估组织结构、评估流程和方法学上的差异与特点。旨在向其他国家学习其成功经验，并将其转化为符合中医药特色的卫生技术评估体系，为我国中医药的医疗保健政策制定者、研究者和从业者提供国际实践经验，从而促进中医药的标准化、现代化和国际化。

Abstract:

Since the United States first introduced the concept of health technology assessment（HTA） in 1976，countries have expanded their focus beyond the assessment of specific clinical treatment methods and means，instead utilizing HTA as a policy tool to judge the adoption and use of new technologies. As a tool to enhance the scientific，economic，and equitable nature of healthcare decision-making，the application of HTA in the field of traditional Chinese medicine（TCM） has been limited in terms of assessment scope，methods，and level of detail，with relatively slow development. By examining the organizational structures，assessment processes，and methodological characteristics of HTA in four European and American countries（the United Kingdom，Canada，Sweden，Germany）and five Asian countries（Japan，Korea，Thailand，Singapore，China），this paper aims to learn from the successful experiences of other countries and transform them into an HTA system that aligns with the unique features of TCM. This provides international practical experience for healthcare policy makers，researchers，and practitioners in China，thereby promoting the standardization，modernization，and internationalization of TCM.